Nimesh Dayal

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

SLE/myositis overlap: are the manifestations of SLE different in overlap disease?

Nimesh Dayal, David Isenberg · Lupus · 2002 · 55 citations

Rheumatology, Autoimmune Disease, Systemic Lupus Erythematosus +15

The natural history of anteroposterior laxity and its role in knee osteoarthritis progression

Nimesh Dayal, Alison H. Chang, Dorothy D. Dunlop et al. · Arthritis & Rheumatism · 2005 · 50 citations

The SLICC Damage Index: past, present and future

Nimesh Dayal, Caroline Gordon, Lori B. Tucker et al. · Lupus · 2002 · 39 citations

Rare Adverse Effect of Treatment With Minocycline

Ashika Odhav, Chirag Odhav, Nimesh Dayal · JAMA Pediatrics · 2014 · 12 citations

Rare Adverse Effect, Website Uses Cookies, Jama Pediatrics Journal +12